Status:
COMPLETED
Allergy Skin Patch Artificial Intelligence (AI)
Lead Sponsor:
Mayo Clinic
Conditions:
Allergic Contact Dermatitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research is to assess human and artificial intelligence performance in grading contact dermatitis reactions in healthy volunteers.
Detailed Description
Study participation involves three visits to the study site on Days 1, 3, and 5, and completion of a demographics and allergy history questionnaire. Researchers will review medical history and current...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Adults over the age of 18
- Willing and able to provide informed consent
- Exclusion Criteria
- Under 18 years of age
- Has used topical or oral steroids two weeks prior to patch testing
- Currently taking immunosuppression agents or is immunocompromised due to medical condition
- No sunburn or rash at site of testing
- Women who are breastfeeding or pregnant.
- Treatment with ultraviolet (UV) light (including tanning) during the two weeks prior to visit.
- Subjects unable to comply with patch test study requirements including multiple return visits and activity restrictions (e.g., protecting patch test area from excess moisture due to showering)
Exclusion
Key Trial Info
Start Date :
February 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 23 2022
Estimated Enrollment :
233 Patients enrolled
Trial Details
Trial ID
NCT05339750
Start Date
February 15 2022
End Date
September 23 2022
Last Update
January 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Florida
Jacksonville, Florida, United States, 32224